Literature DB >> 12031700

Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9.

Anne M Romanic1, Stephen M Harrison, Weike Bao, Cynthia L Burns-Kurtis, Susan Pickering, Juanli Gu, Evelyn Grau, Joyce Mao, Ganesh M Sathe, Eliot H Ohlstein, Tian Li Yue.   

Abstract

OBJECTIVE: Matrix metalloproteinase-9 (MMP-9) activity is up regulated in the heart subjected to ischemic insult. Whether increased MMP-9 activity contributes to acute myocardial injury after ischemia-reperfusion remains unknown. To investigate the role of MMP-9 in myocardial infarction, we utilized a MMP-9 knockout mouse. METHODS AND
RESULTS: Standard homologous recombination in embryonic stem cells was used to generate a mouse lacking MMP-9. The left anterior descending coronary artery was occluded for 30 min followed by 24 h reperfusion, and the ischemic and infarct sizes were determined. Targeted deletion of MMP-9 protected the heart from no-flow ischemia-reperfusion-induced myocardial injury. The myocardial infarct size was reduced by 17.5% in MMP-9 heterozygotes (+/-) (P<0.01) and 35.4% in MMP-9 knockout (-/-) mice (P<0.01) versus the wild-type (+/+) mice, respectively. Analysis of MMP activity in myocardial extracts by zymography demonstrated that ischemia-reperfusion-induced expression of proMMP-9 and active MMP-9 was reduced by 77.8% (P<0.01) and 69.1% (P<0.001), respectively, in (+/-) mice compared to (+/+) mice, and was absent in (-/-) animals. The expression of TIMP-1, an endogenous inhibitor of MMP-9, was elevated 4.7-fold (P<0.05) and 21.4-fold (P<0.05) in the (+/-) and (-/-) mice, respectively, compared to (+/+) mice. Immunohistochemical analysis revealed that neutrophils were the primary cellular source of MMP-9, and less neutrophils were detected in the ischemic region of the heart following ischemia-reperfusion in (-/-) mice compared to (+/+) mice. Measurement of myeloperoxidase activity, a marker enzyme of neutrophils, demonstrated a 44% reduction in neutrophils infiltrated into the ischemic myocardium in the (-/-) mice compared to the (+/+) mice (P<0.05).
CONCLUSION: These results suggest that MMP-9 plays an important role in ischemia-reperfusion-induced myocardial infarction and MMP-9 could be a target for prevention or treatment of acute ischemic myocardial injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031700     DOI: 10.1016/s0008-6363(02)00254-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  44 in total

Review 1.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

2.  Matrix metalloproteinases and membrane damage markers in sera of patients with acute myocardial infarction.

Authors:  Kristina Gopcevic; Branislav Rovcanin; Dusan Kekic; Sandra Radenkovic
Journal:  Mol Cell Biochem       Date:  2010-12-28       Impact factor: 3.396

Review 3.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

4.  Cardiac stem cell niche, MMP9, and culture and differentiation of embryonic stem cells.

Authors:  Paras Kumar Mishra; Nicholas John Kuypers; Shree Ram Singh; Noel Diaz Leiberh; Vishalakshi Chavali; Suresh C Tyagi
Journal:  Methods Mol Biol       Date:  2013

5.  Generating double knockout mice to model genetic intervention for diabetic cardiomyopathy in humans.

Authors:  Vishalakshi Chavali; Shyam Sundar Nandi; Shree Ram Singh; Paras Kumar Mishra
Journal:  Methods Mol Biol       Date:  2014

6.  MMP9 inhibition increases autophagic flux in chronic heart failure.

Authors:  Shyam S Nandi; Kenichi Katsurada; Neeru M Sharma; Daniel R Anderson; Sushil K Mahata; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

7.  Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling.

Authors:  Baohong Jiang; Jing Chen; Lingling Xu; Zhenting Gao; Yanping Deng; Yanhui Wang; Feng Xu; Xu Shen; De-An Guo
Journal:  BMC Pharmacol       Date:  2010-08-25

8.  Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat.

Authors:  Henrique S Rosário; Stephen W Waldo; Scott A Becker; Geert W Schmid-Schönbein
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 9.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 10.  MMP induction and inhibition in myocardial infarction.

Authors:  Merry L Lindsey
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.